Free Trial

Clarivate (CLVT) Competitors

Clarivate logo
$5.44 +0.08 (+1.40%)
Closing price 03:59 PM Eastern
Extended Trading
$5.53 +0.09 (+1.73%)
As of 06:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CLVT vs. RTO, CART, ALLE, FTAI, MEDP, ULS, WPP, GLOB, HQY, and STN

Should you be buying Clarivate stock or one of its competitors? The main competitors of Clarivate include Rentokil Initial (RTO), Maplebear (CART), Allegion (ALLE), FTAI Aviation (FTAI), Medpace (MEDP), UL Solutions (ULS), WPP (WPP), Globant (GLOB), HealthEquity (HQY), and Stantec (STN). These companies are all part of the "business services" industry.

Clarivate vs.

Clarivate (NYSE:CLVT) and Rentokil Initial (NYSE:RTO) are both computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, media sentiment, valuation, community ranking, dividends and analyst recommendations.

Clarivate received 44 more outperform votes than Rentokil Initial when rated by MarketBeat users. Likewise, 53.93% of users gave Clarivate an outperform vote while only 30.77% of users gave Rentokil Initial an outperform vote.

CompanyUnderperformOutperform
ClarivateOutperform Votes
48
53.93%
Underperform Votes
41
46.07%
Rentokil InitialOutperform Votes
4
30.77%
Underperform Votes
9
69.23%

Rentokil Initial has higher revenue and earnings than Clarivate.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clarivate$2.63B1.47-$911.20M-$1.99-2.74
Rentokil Initial$6.68B1.80$473.93MN/AN/A

Rentokil Initial has a net margin of 0.00% compared to Clarivate's net margin of -50.00%. Clarivate's return on equity of 9.69% beat Rentokil Initial's return on equity.

Company Net Margins Return on Equity Return on Assets
Clarivate-50.00% 9.69% 3.97%
Rentokil Initial N/A N/A N/A

85.7% of Clarivate shares are held by institutional investors. Comparatively, 9.9% of Rentokil Initial shares are held by institutional investors. 23.1% of Clarivate shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Rentokil Initial had 18 more articles in the media than Clarivate. MarketBeat recorded 26 mentions for Rentokil Initial and 8 mentions for Clarivate. Clarivate's average media sentiment score of 0.90 beat Rentokil Initial's score of 0.02 indicating that Clarivate is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Clarivate
4 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Rentokil Initial
2 Very Positive mention(s)
0 Positive mention(s)
21 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Neutral

Clarivate has a beta of 1.14, meaning that its stock price is 14% more volatile than the S&P 500. Comparatively, Rentokil Initial has a beta of 1.08, meaning that its stock price is 8% more volatile than the S&P 500.

Clarivate currently has a consensus target price of $7.10, indicating a potential upside of 30.16%. Rentokil Initial has a consensus target price of $29.00, indicating a potential upside of 21.95%. Given Clarivate's higher probable upside, equities analysts clearly believe Clarivate is more favorable than Rentokil Initial.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Clarivate
1 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.17
Rentokil Initial
0 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
2.63

Summary

Clarivate beats Rentokil Initial on 10 of the 17 factors compared between the two stocks.

Get Clarivate News Delivered to You Automatically

Sign up to receive the latest news and ratings for CLVT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CLVT vs. The Competition

MetricClarivateData processing & preparation IndustryComputer SectorNYSE Exchange
Market Cap$3.88B$4.41B$27.15B$20.03B
Dividend YieldN/A2.69%2.73%3.61%
P/E Ratio-2.7433.64235.8241.99
Price / Sales1.477.643,380.0217.38
Price / Cash2.7930.7035.2920.20
Price / Book0.796.158.655.75
Net Income-$911.20M$42.31M$670.02M$1.01B
7 Day Performance7.17%2.24%2.60%1.78%
1 Month Performance9.54%5.73%7.48%5.72%
1 Year Performance-40.67%20.68%27.67%18.76%

Clarivate Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CLVT
Clarivate
3.4463 of 5 stars
$5.44
+1.4%
$7.10
+30.6%
-42.0%$3.86B$2.63B-2.7312,000News Coverage
RTO
Rentokil Initial
2.076 of 5 stars
$23.82
-0.8%
$29.00
+21.8%
-9.3%$12.02B$6.68B0.0062,900
CART
Maplebear
3.691 of 5 stars
$46.32
-0.6%
$48.31
+4.3%
+78.5%$11.90B$3.04B31.093,380Analyst Revision
ALLE
Allegion
3.9276 of 5 stars
$133.72
+0.8%
$140.83
+5.3%
+10.5%$11.62B$3.65B20.5412,400Positive News
FTAI
FTAI Aviation
4.2974 of 5 stars
$112.38
-6.4%
$177.33
+57.8%
+67.0%$11.52B$1.55B-1,123.6940Analyst Upgrade
News Coverage
High Trading Volume
MEDP
Medpace
4.6114 of 5 stars
$337.35
+0.2%
$380.56
+12.8%
+17.5%$10.48B$1.89B29.545,900
ULS
UL Solutions
1.353 of 5 stars
$51.94
+0.0%
$49.00
-5.7%
N/A$10.39B$2.68B0.0015,233
WPP
WPP
1.2646 of 5 stars
$45.13
+1.1%
N/A-0.9%$9.74B$18.46B0.00114,732
GLOB
Globant
4.4642 of 5 stars
$213.48
-1.6%
$230.44
+7.9%
-9.2%$9.20B$2.35B55.7429,150Analyst Forecast
News Coverage
HQY
HealthEquity
2.9164 of 5 stars
$102.42
+2.3%
$110.71
+8.1%
+43.2%$8.88B$999.59M93.963,150Positive News
STN
Stantec
3.7996 of 5 stars
$77.49
+1.2%
N/A-2.6%$8.84B$4.80B35.2228,000Analyst Revision
Positive News

Related Companies and Tools


This page (NYSE:CLVT) was last updated on 1/22/2025 by MarketBeat.com Staff
From Our Partners